Post-Approval Study of the Neuspera Sacral Neuromodulation System
RecruitingNCT07144813Phase: NAStarted 2025-09-03
Summary
Prospective, multi-center, single-arm, post-approval study is designed to assess the long-term safety and efficacy data of the Neuspera Sacral Neuromodulation (SNM) System following commercial approva
Eligibility
Sex
ALL
Min Age
22 Years
Max Age
None
Locations
Kaiser Permanente Point Loma MOBSan Diego, California, United States
Genesis Healthcare PartnersSan Diego, California, United States
Florida Urology PartnersTampa, Florida, United States
Women's Health Advantage,Fort Wayne, Indiana, United States
Indiana University, School of MedicineIndianapolis, Indiana, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07144813